Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2965045 | 0.86 | MEN1 (0.37) | MEN1KMT2AGAA | |
| SCHEMBL2973101 | 0.84 | MEN1 (0.33) | MEN1KMT2AGAA | |
| SCHEMBL2964780 | 0.82 | MEN1 (0.31) | MEN1KMT2AGAA | |
| SCHEMBL15661810 | 0.82 | KDM1A (0.38) | MEN1KMT2AGAAHTR6HTR2A | |
| SCHEMBL29606130 | 0.82 | KDM1A (0.38) | MEN1KMT2AGAAHTR6HTR2A | |
| SCHEMBL2965693 | 0.81 | MEN1 (0.35) | MEN1KMT2AGAA | |
| SCHEMBL2959983 | 0.80 | ALDH1A1 (0.34) | MEN1KMT2AGAA | |
| SCHEMBL2963875 | 0.80 | CYP1A2 (0.33) | MAPT | |
| SCHEMBL2971027 | 0.78 | HTR6 (0.32) | HTR6HTR2A | |
| SCHEMBL2959129 | 0.77 | MEN1 (0.31) | MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | MEN1 750/4885KMT2A 1517/4885GAA 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.